LAURUS LABS LIMITED Financial Ratios
LAURUSLABS · Healthcare · Current price ₹1,857
P/E ratio
112.8x
P/B ratio
15.7x
ROE
18.3%
ROCE
18.0%
Debt / Equity
0.40
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 112.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 15.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 18.3% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 18.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.40 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with LAURUS LABS LIMITED's latest numbers.
LAURUS LABS LIMITED profitability
LAURUS LABS LIMITED generates a return on equity of 18.3% and a return on capital employed of 18.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.40 and a P/E of 112.8x, LAURUS LABS LIMITED is conservatively financed. Our overall business-quality score for the company is 4.4 / 10.
Understand the ratios
More on LAURUS LABS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.